Sharekhan

BUY NOW Buy Fredun Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Fredun Pharmaceuticals Ltd

Fri 29/08/2025,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Fredun Pharmaceuticals Ltd

Your Vote -

Buy

25.00%

Hold

50.00%

Sell

25.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Fredun Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 Aug 2025, 3:46PM Pursuant to Regulation 30 read with sub para 15, Para A Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requi

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    6 Aug 2025, 6:13PM TRANSCRIPT OF THE EARNINGS CONFERENCE CALL HELD ON 1ST AUGUST 2025 FOR Q1 FY26 RESULTS.

  • Fredun Pharma - Audio Recording Of The Q1 FY26 'Earnings Conference Call'

    1 Aug 2025, 8:04PM Audio Recording of the Q1 FY26 \Earnings Conference Call\

  • Fredun Pharma - Audio Recording Of The Q1 FY25 'Earnings Conference Call'

    1 Aug 2025, 7:07PM Audio Recording of the Q1 FY25 \Earnings Conference Call\

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    31 Jul 2025, 1:13PM Press release issued by Fredun Pharmaceuticals Limited.

  • Fredun Pharma - Appointment Of Non-Executive Independent Directors.

    30 Jul 2025, 7:20PM Appointment of Non-Executive Independent Directors Mr. Anshu Agarwal and Mrs. Sonal Desai.

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate

    30 Jul 2025, 7:14PM Appointment of non-excecutive Independent Directors.

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    30 Jul 2025, 7:06PM Appointment of Non-Executive Independent Directors Mr. Anshu Agarwal and Mrs. Sonal Desai.

  • Fredun Pharma Q1 net profit jumps 63.92% at Rs 6.77 cr

    30 Jul 2025, 7:01PM The company reported standalone net profit of Rs 6.77 crore for the quarter ended June 30, 2025 as compared to Rs 4.13 crore in the same period last y

  • Fredun Pharma - Results For The Quarter Ended 30Th June 2025.

    30 Jul 2025, 6:54PM Un-audited Results of the Company for the quarter ended 30th June 2025 along with Limited review report.

  • Fredun Pharma - Board Meeting Outcome for Outcome Of Board Meeting

    30 Jul 2025, 6:45PM Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Dir

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Jul 2025, 4:29PM Pursuant to Regulation 30 read with sub para 15, Para A Part A Schedule III of the Securities and Exchange Board of India Listing Obligations and Disc

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    29 Jul 2025, 8:08PM Intimation of Earnings Conference Call for the quarter ended 30th June, 2025

  • Fredun Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:10PM As of June 2025, 48.93% is owned by Indian Promoters and 51.07% by Public. <p align=justify> Top three Promoters holding highest number of shares of F

  • Fredun Pharma - Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Wednesday, 3

    14 Jul 2025, 5:55PM Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consid

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    10 Jul 2025, 6:59PM Voluntary Disclosure - SEBI Adjudication Order Dated June 30, 2025 (No Penalty Imposed)

  • Fredun Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2025, 5:37PM Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018.

  • Fredun Pharma - Voluntary Disclosure - SEBI Adjudication Order Dated June 30, 2025 (No Penalty Imposed)

    3 Jul 2025, 9:13PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with our internal policy on d

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 Jun 2025, 12:29PM Fredun Pharmaceuticals enters pet care market with one pet stop acquisition.

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Demise

    20 Jun 2025, 7:08PM Intimation of demise of Mr. Nariman Medhora under Regulation 30 of SEBI (LODR) Reg, 2015

  • Fredun Pharma - Investors Presentation Issued By Fredun Pharmaceuticals Limited Stating Annual Review & Strategic Outlook For

    10 Jun 2025, 1:30PM INVESTORS PRESENTATION

  • Fredun Pharma - Investor Presentation Of Fredun Pharmaceuticals Limited

    10 Jun 2025, 11:49AM INVESTOR PRESENTATION OF FREDUN PHARMACEUTICALS LIMITED

  • Fredun Pharma Q4 net profit up 39.72% at Rs 7.07 cr

    2 Jun 2025, 9:20AM The company reported standalone net profit of Rs 7.07 crore for the quarter ended March 31, 2025 as compared to Rs 5.06 crore in the same period last

  • Fredun Pharma - Revised Outcome Of The Board Meeting Dated 30.05.2025

    31 May 2025, 8:32PM Revised Outcome of the Board Meeting dated 30.05.2025

  • Fredun Pharma - Standalone And Consolidated Audited Financial Results For The Quarter And Financial Year Ended March 31, 2025

    31 May 2025, 7:59PM Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2025 along with Statement of Assets and Liabi

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    31 May 2025, 1:26AM Press Release of Fredun Pharmaceuticals for Q4 and FY25 Robust Performance.

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    31 May 2025, 1:13AM Intimation of re-appointment of Secretarial Auditor, Internal Auditor and Cost Auditor.

  • Fredun Pharma - Standalone And Consolidated Financial Results For The Period Ended On 31St March 2025.

    31 May 2025, 1:04AM Standalone and Consolidated Financial results for the period ended on 31st March 2025.

  • Fredun Pharma - Board Meeting Outcome for Outcome Of Board Meeting

    31 May 2025, 12:57AM To consider approve and adopt The Standalone and consolidated Audited Financial Results for the Quarter and Financial year ended March, 31 2025
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Fredun Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 307.8076 226.9811 182.9008 120.825 82.7105
Liabilities 307.8076 226.9811 182.9008 120.825 82.7105
Equity 4.7217 4.6992 4.5323 4.4326 3.9896
Gross Profit 50.5345 37.9823 27.7774 13.7953 9.1395
Net Profit 20.8076 15.6234 10.8066 6.3353 2.0146
Cash From Operating Activities -28.8833 -0.4387 -14.4088 -2.3802 0.1699
NPM(%) 4.6 4.48 3.93 2.82 1.5
Revenue 451.7062 348.1562 274.6756 224.4595 133.8933
Expenses 401.1717 310.1739 246.8982 210.6642 124.7538
ROE(%) 15.89 11.93 8.25 4.84 1.53

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fredun Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 802.00 0.50 72.66 656.47 301.39 0.62
Lotus Eye Hospital and Institute Ltd 116.91 6.94 376.90 2392.09 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 21.30 -1.07 0.00 4966.78 -39.50 0.00
Astec Lifesciences Ltd 879.30 2.33 0.00 2255.80 -604.77 0.00

Company Info

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers.

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers.

Read More

Parent Organisation

Fredun Pharmaceuticals Ltd.

Founded

08/06/1987

Managing Director

Dr.(Mrs.)Daulat N Medhora

NSE Symbol

FAQ

The current price of Fredun Pharmaceuticals Ltd is

The 52-week high for Fredun Pharmaceuticals Ltd is

The market capitalization of Fredun Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fredun Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fredun Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fredun Pharmaceuticals Ltd shares.

The CEO of Fredun Pharmaceuticals Ltd is Dr.(Mrs.)Daulat N Medhora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT